- Home
- OSCR vs ALKS Comparison
OSCR vs ALKS Comparison
Compare OSCR & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OSCR | ALKS |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 8.7B |
| IPO Year | 2021 | 2012 |
Fundamental Metrics
Financial Performance| Metric | OSCR | ALKS |
|---|---|---|
| Price | $29.80 | $40.84 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 19 |
| Target Price | $35.40 | ★ $56.56 |
| AVG Volume (30 Days) | ★ 4.6M | 1.7M |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.16 | N/A |
| Revenue | ★ $11,701,427,000.00 | $1,475,899,000.00 |
| Revenue This Year | $60.08 | $23.57 |
| Revenue Next Year | $11.01 | $6.48 |
| P/E Ratio | $9.48 | ★ N/A |
| Revenue Growth | ★ 27.50 | N/A |
| 52 Week Low | $10.69 | $27.00 |
| 52 Week High | $34.48 | $55.67 |
Technical Indicators
Market Signals| Indicator | OSCR | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 49.59 | 31.74 |
| Support Level | $28.16 | $36.25 |
| Resistance Level | $32.73 | $51.25 |
| Average True Range (ATR) | 1.60 | 1.42 |
| MACD | -0.19 | -0.27 |
| Stochastic Oscillator | 41.10 | 15.22 |
Price Performance
Historical ComparisonAbout OSCR Oscar Health Inc.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.